Companies: 10,795·Total market cap: $144.5T
Avantor, Inc.

Avantor, Inc.

AVTRNYSEHealthcare● Active
$9.16
$-0.36(-3.78%)
Market Cap$6.3B
P/E Ratio
52W High$15.93
52W Low$7.265
SEC Filings

Avantor, Inc. (AVTR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001722482 · AVTR · NYSE · as of Jun 8, 2026

Filing snapshot

766
Total Filings
SD
Latest Form
2026-05-29
Most Recent
2019
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001722482 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-11
Fiscal Year End
Feb 11, 2026
Accession No.
0001628280-26-007118
Primary Document
avtr-20251231.htm
Source: data.sec.gov · CIK 0001722482 · Accession 0001628280-26-007118

Latest Key Filings

10-QQuarterly Report
10-Q
2026-04-29
8-KCurrent Report
8-K
2026-05-12Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-05-29
View
8-KCurrent Report
8-K
2026-05-12
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-05-05
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
10-QQuarterly Report
10-Q
2026-04-29
View
8-KCurrent Report
8-K
2026-04-29
View
8-KCurrent Report
8-K
2026-04-23
View
8-KCurrent Report
8-K
2026-04-01
View
ARSARS
ANNUAL REPORT TO SECURITY HOLDERS
2026-03-27
View
DEFA14AProxy Statement (Additional)
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
2026-03-27
View
DEF 14AProxy Statement
DEFINITIVE PROXY STATEMENT
2026-03-27
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
8-K/ACurrent Report (Amended)
8-K/A
2026-02-25
View
8-K/ACurrent Report (Amended)
8-K/A
2026-02-25
View
8-KCurrent Report
8-K
2026-02-11
View
Showing 1–15 of 311 filingsForm 4 / 144 hidden· 766 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001722482  |  Exchange: NYSE · Healthcare

Avantor, Inc. (NYSE: AVTR) has submitted 766 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001722482, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Avantor, Inc.'s most comprehensive regulatory disclosure. The most recent Avantor, Inc. 10-K was filed on 2026-02-11 for fiscal year ending 2026. Historical AVTR 10-K annual reports are available from 2017 through 2026.

Investors researching Avantor, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

AVTR SEC Filings · 8 questions

Avantor, Inc. (AVTR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 766 filings and access original documents at no cost. Avantor, Inc.'s CIK is 0001722482.

AVTR SEC filingsAvantor, Inc. SEC documentsfind AVTR 10-K